The Global Drugs of Abuse Testing Market is expected to grow at a CAGR of 6.50% during the forecast period. Increase in demand for therapy for substance abuse is one of the crucial factors anticipated to boost the market. Morbidity and mortality due to drug abuse are rising globally. One in every 4 deaths is attributed to tobacco, alcohol, and illicit drug consumption. The overdose of opioids results in adverse and serious health conditions. In the U.S., the nonmedical use of prescription opioids has considerably increased.
North America is holding the major market share of drugs of abuse testing market among other regions. The Asia Pacific is accounting the major growth rate for this market during the forecast period. The market for drugs of abuse testing, which can be an in-house or onsite examination of drugs within a human body, is gaining traction from a number of factors such as advancements in technology of analyzers, increasing availability of forbidden drugs, and growing emphasis on work place screening among the urban populations.
Global Drugs of Abuse Testing market is segregated on the basis of Product type as rapid testing devices, analyzers, consumables. Based on sample type, the global Drugs of Abuse Testing market is segmented in urine, salvia, blood, breath, hair and sweat. The report also bifurcates global Drugs of Abuse Testing market based on end user in on-the-spot testing, hospitals, forensic laboratories and diagnostic laboratories.
Global Drugs of Abuse Testing market report provides geographic analysis covering regions such as North America, Europe, Asia Pacific, and Rest of World. The Drugs of Abuse Testing market for each region is further segmented for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.
Competitive Rivalry
Abbott Laboratories, Dako, Biomedical Diagnostics are among the major players in the global Drugs of Abuse Testing market share. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Drugs of Abuse Testing Market has been segmented as below:
Drugs of Abuse Testing Market, by Product Type
Drugs of Abuse Testing Market, by Sample Type
Drugs of Abuse Testing Market, by End User
Drugs of Abuse Testing Market, By Region
The report covers:
Report scope:
Global Drugs of Abuse Testing market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Drugs of Abuse Testing market share. Major industry players with significant revenue share include LGC Ltd., Alere, Randox Testing Services, ATI, Inc. etc.
Reasons to Buy this Report:
Customization:
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.2.1. Advancements in technology
4.2.2. Convenient device considering its portability
4.3. Restraints
4.3.1. Lack of awareness regarding availability of drug testing
4.3.2. Disobeying the privacy rights
5. Drugs of Abuse Testing Market, By Product Type
5.1. Key Points
5.2. Rapid Testing Devices
5.3. Analyzers
5.4. Consumables
6. Drugs of Abuse Testing Market, By Sample Type
6.1. Key Points
6.2. Urine
6.3. Salvia
6.4. Blood
6.5. Breath
6.6. Hair
6.7. Sweat
7. Drugs of Abuse Testing Market, By End User
7.1. Key Points
7.2. On-The-Spot Testing
7.3. Hospitals
7.4. Forensic Laboratories
7.5. Diagnostic Laboratories
8. Competitive Landscape
8.1. Introduction
8.2. Recent Developments
8.2.1. Mergers &Acquisitions
8.2.2. New Product Developments
8.2.3. Portfolio/Production Capacity Expansions
8.2.4. Joint Ventures, Collaborations, Partnerships & Agreements
8.2.5. Others
9. Company Profile
9.1. Danaher Corporation
9.1.1. Company Overview
9.1.2. Product/Service Landscape
9.1.3. Financial Overview
9.1.4. Recent Developments
9.2. Abbott Laboratories.
9.2.1. Company Overview
9.2.2. Product/Service Landscape
9.2.3. Financial Overview
9.2.4. Recent Developments
9.3. Laboratory of Corporation of America Holding
9.3.1. Company Overview
9.3.2. Product/Service Landscape
9.3.3. Financial Overview
9.3.4. Recent Developments
9.4. Thermo Fisher Scientific Inc.
9.4.1. Company Overview
9.4.2. Product/Service Landscape
9.4.3. Financial Overview
9.4.4. Recent Developments
9.5. LGC Ltd.
9.5.1. Company Overview
9.5.2. Product/Service Landscape
9.5.3. Financial Overview
9.5.4. Recent Developments
9.6. Alere
9.6.1. Company Overview
9.6.2. Product/Service Landscape
9.6.3. Financial Overview
9.6.4. Recent Developments
9.7. Graphic Packaging Group
9.7.1. Company Overview
9.7.2. Product/Service Landscape
9.7.3. Financial Overview
9.7.4. Recent Developments
The Drugs of Abuse Testing Market has been segmented as below:
Drugs of Abuse Testing Market, by Product Type
Drugs of Abuse Testing Market, by Sample Type
Drugs of Abuse Testing Market, by End User
Drugs of Abuse Testing Market, By Region
SUBSCRIBE TO OUR NEWSLETTERS
